Dr. O'Bryan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
171 Ashley Ave
Charleston, SC 29425Phone+1 843-792-1414Fax+1 877-303-1460
Education & Training
- MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 2021 - 2024
- Virginia Commonwealth University School of MedicineClass of 2021
- University of North Carolina at Chapel HillBS, Chemistry, 2012 - 2015
Certifications & Licensure
- SC State Medical License 2024 - 2025
- DC State Medical License 2021 - 2024
- VA State Medical License 2021 - 2024
Publications & Presentations
Journal Articles
- Gender Disparities in Outcomes of Cardiac Procedures with Amyloidosis using the National Inpatient Sample 2016-2019Iyer, A., Dewaswala, N., Harris, C., Bhopalwala, H., Munshi, R.F., Towheed, A., Gupta, S., Minhas, A., Gaurang, V.N., Mishra, V., & O’Bryan, J., Journal of the Society for Cardiovascular Angiography and Interventions, 5/2022
- Characteristics of Patients Presenting to Emergency Department for Primary Atrial Fibrillation or Flutter at an Academic Medical CenterSadaf, M.I., O’Bryan, J., Biese, K., Chen, S., Deyo, Z., Mendys, P., Sears, S.F., Tuttle, H., Walker, T.J., & Gehi, A.K., Indian Heart Journal, 8/2021
- Risk Stratified Tandem Versus Single Autologous Stem Cell Transplantation for Multiple Myeloma Yields Equivalent SurvivalSing, K., Sabo, R., O’Bryan, J., Risendal, M., Roberts, C., & Toor, A., American Society of Hematology, 11/5/2020
- Join now to see all
Abstracts/Posters
- Phase II clinical trial of olaparib plus pembrolizumab in the treatment of patients with advanced biliary tract cancerO’Bryan, J., Yin, C., Weinberg, B.A., Noel, M.S., Mukherji, R., Kulasekaran, M., Agarwal, S., Kupfer, G., Wang, H., Hartley, M.L., Marshall, J., & He, A.R., Journal of Clinical Oncology, 6/2023
- Phase II Clinical Trial of Olaparib plus Pembrolizumab in the Treatment of Patients with Advanced Biliary Tract CancerO’Bryan, J., Yin, C., Weinberg, B.A., Noel, M.S., Mukherji, R., Kulasekaran, M., Agarwal, S., Kupfer, G., Wang, H., Hartley, M.L., Marshall, J., & He, A.R., American Society of Clinical Oncology's Annual Meeting, Chicago, IL, 6/2023
- Phase II Clinical Trial of Olaparib plus Pembrolizumab in the Treatment of Patients with Advanced Biliary Tract CancerO’Bryan, J., Yin, C., Weinberg, B.A., Noel, M.S., Mukherji, R., Kulasekaran, M., Agarwal, S., Kupfer, G., Wang, H., Hartley, M.L., Marshall, J., & He, A.R., MedStar Health-Georgetown University Research & Education Symposium, Bethesda, MD, 5/2023
- Join now to see all
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: